Enhancing Innate Anti-Viral Resistance Through A Community-Based Intervention - Generation Xchange
About
Brief Summary
This randomized controlled trial will test whether a recently developed community-based intergenerational mentoring program known as Generation Xchange (GenX) can enhance antiviral resistance in older African-American women and men in a low-SES urban community. Additional studies will identify the biological processes that promote resistance to respiratory virus infections and viral disease in older African-American women and men.
Primary Purpose
Study Type
Phase
Eligibility
Gender
Healthy Volunteers
Minimum Age
Maximum Age
Inclusion Criteria:
- Participating in the GenX intergenerational mentoring program
- All GenX mentors > 50 years of age are eligible to participate in this research
- GenX program participation requires:
- Reside in neighborhood of GenX schools (South-Central Los Angeles)
- Pass basic literacy and cognitive function tests
Exclusion Criteria:
- Any health condition that would put participant at risk by enrollment/participation
Join this Trial
Enrolling by Invitation
These studies are not open to everyone who meets the eligibility criteria, but
only to people in that particular population, who are specifically invited to participate.
Study Stats
Protocol No.
21-001388
Category
Infectious Diseases
Principal Investigator
Teresa Seeman
Contact
Location
- UCLA Westwood